# BioNexus Gene Lab Corp: Form 8-K, filed Oct 10, 2024

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2024-10-10
- Accepted by EDGAR: Oct 10, 2024, 21:29 ET
- Period: 2024-10-04
- Accession: 0001477932-24-006352
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224006352/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793224006352/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793224006352/bglc_8k.htm

Filed Oct 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001477932-24-006352. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.